GlassScriptPhysician profile
Jennifer P Porter
NPI 1831259571
$2,207.42
in general payments reported to CMS, 2019-2025
10 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2021: $425 · 2022: $203 · 2023: $229 · 2024: $312 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $717.17 | 2019-2023 | |
| Abbvie INC. | $531.12 | 2023-2025 | |
| Galderma Laboratories, L.P. | $269.60 | 2022-2025 | |
| Revance Therapeutics, INC. | $139.47 | 2024-2025 | Daxxify |
| Medtronic Vascular, INC. | $137.94 | 2019 | |
| Acclarent, INC | $124.03 | 2019 | |
| Axogen | $115.38 | 2019 | |
| Apyx Medical Corporation | $86.75 | 2019 | |
| Merz North America, INC. | $51.44 | 2019 | |
| Kite Pharma, INC. | $34.52 | 2024 | Yescarta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.